drugset / Trial / NCT01490177

Single Center Food Allergy Oral Immunotherapy Study

NCT01490177 ↗

Phase 1 Completed 50 enrolled Stanford University
NaSingle-groupOpen-labelTreatment

Summary

The Primary Objective of the study is to develop a customized regimen for oral immunotherapy that reflects what the subject is allergic in a clinically significant way (i.e., the offending food allergen is defined as a food allergen with a positive skin test or positive specific IgE and a positive DBPCFC). Therefore, the investigators prefer that both single and multiple food allergy subjects are included in the study.

Timeline

Start
2011-11
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Food proteins Unknown — Oral